Vaccination with recombinant (r) hsp60 protects mice against Histoplasma capsulatum. To map the domain of rhsp60 that confers protection, four gene segments were cloned into pET19b and expressed in Escherichia coli. rhsp60 fragments were tested for their capacity to induce proliferation by sensitized splenocytes and to protect BALB/c and C57BLl6 mice. All polypeptides stimulated cells from BALB/c mice immunized with yeasts or with rhsp60. Fragment 3 caused the most vigorous response by cells from mice immunized with yeasts, and fragment 1 caused the most vigorous response by cells from mice immunized with rhsp60. Splenocytes from yeast-immunized C57BLl6 mice did not recognize any polypeptide. In contrast, cells from C57BLl6 mice inoculated with rhsp60 responded to all fragments but most intensely to fragment 2. In both strains, fragment 3 conferred protection against sublethal and lethal challenges. Thus, a common protective domain of hsp60 has been identified.
The generation of a protective immune response to the pathogenic fungus Histoplasma capsulatum is critically dependent on an interaction between antigen-reactive T cells and macrophages. T cells must recognize degraded fragments ofH. capsulatum proteins in order to release cytokines that are necessary to activate phagocytes to express an antifungal effect. Several crude extracts from this fungus can confer protection in experimental animals [1 -3] . hsp60 isolated from an extract of the cell wall and cell membrane of H. capsulatum yeasts stimulates the development of protective immunity [4] . Moreover, we have shown that recombinant hsp60 (rhsp60) protects BALBI c mice against lethal challenge with H. capsulatum yeasts [4, 5] .
In this study, we sought to extend these findings to determine if there is a domain or domains within rhsp60 that function similarly to the entire protein. The intent was to see if a particular amino acid sequence of hsp60 is responsible for its protective efficacy. Four overlapping protein fragments were produced using recombinant DNA technology.
Materials and Methods
Mice. Male BALB/c and C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME). Animals were housed under standard laboratory conditions.
Antibody. Monospecific rabbit anti -H. capsulatum hsp60 was prepared as described [5] .
Cloning and expression of gene fragments from hsp60. Four gene fragments were isolated from the cDNA of hsp60 by use of polymerase chain reaction (PCR). To amplify each fragment, sense and antisense primers (final concentration, I J.1,M) were incubated with 50 ng of pET19b (Novagen, Madison, WI) containing the full-length cDNA of hsp60 [5] , 200 f-LM each dNTP (Pharmacia Biotech, Piscataway, NJ), and 5 U of Vent polymerase (New England Biolabs, Beverly, MA). PCR was done for 25 cycles (I5 s at 94°C, 20 s at 60°C, and 2 min at 72°C). The primers (sense and antisense [5'-3'] , respectively) used for fragment I (FI) were CAAGCATATGAAGGAGCTCAAATTCGGCGT and AGCCGGATCCGAGGATGCTCTTGCGGTTG, for fragment 2 (F2) were TGAATTCCATA TGGTCCTTGCTCGGGCTATT and AGCCGGATCCAGTGGTGGGGTCAGCGATG, for fragment 3 (F3) were CGAATTCCATATGGTCAAGGACGGAAAGACCA and AGCCGGATCCGGCGGACTTGACGATGCTG, and for fragment 4 (F4) were AGAATTCCATATGGATGGCAGCAA-GGATTC and TTAAGCTTAGAACATGCCACCGCCCA. The sense primers introduce an NdeI site (underlined); the antisense primers introduce a BamHI site (italicized) or HindlJI site (bold).
The amplified products were gel-purified with I % low-melting-point agarose (FMC, Rockland, ME) and digested with the appropriate restriction enzymes. DNAwas cloned into the NdeIBamHI site of pET19b or, for F4, the NdeI-Hindlil site of the plasmid and transformed into Escherichia coli BL21 (DE3) lysogen host cells. Fidelity of the sequences was confirmed by DNA sequencing.
Protein expression. To express the recombinant proteins, I L of transformed E. coli was grown in Luria-Bertani medium at 37°C in a shaking incubator until it had an OD 6oo of 0.5. Subsequently, isopropyl-thiogalactose was added to cultures to a final concentration of I mM, and cultures were incubated for an additional 2-3 h. Cells were harvested by centrifugation at 5000 g. E. coli pellets were resuspended in a buffer consisting of 5 mM imidazole, 500 mM NaCI, and 20 mM TRIS-CI, pH 7.9, and lysed by a freezethaw cycle followed by sonication. Soluble and insoluble fractions were separated by centrifugation at 20,000 g. F1-F3 were found in the insoluble inclusion bodies of E. coli. whereas F4 was located in the soluble fraction of the sonicated material.
Metal chelate purification ofexpressed proteins. The insoluble pellet fragments were resuspended by sonication in a denaturing solubilization buffer consisting of 6 M urea, 500 mM NaCI, 5 mM 
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Isolation and expression ofgene fragments of hsp60. Four fragments of hsp60 were amplified by peR from the cDNA of this gene and cloned into the NdeI site of the expression vector, pET19b. The fragments were 855, 792, 813, and 651 bp in size; thus, the gene segments encoded aa 1-285, 89-353, 172-443, and 331-548. They were designed to encode an overlap of , . . . . . , 100 aa, except for the overlap between recombinant F 1 and F2, which was 196 aa (figure 1). The selections for amplification were based on the adequacy of primers and expression levels by E. coli. The fragments were expressed in E. coli and purified by metal chelate chromatography and analyzed by SDS-PAGE. Fl, F2, and F3 each had a relative molecular mass of 37 kDa, and F4 had a molecular mass of 31 kDa (figure 2). The bands were immunoblotted with polyclonal rabbit antiserum or with preimmune serum. Each fragment was immunoreactive with the rabbit antiserum but not with the preimmune serum ( figure 3 ). In addition, these gene segments were sequenced to confirm the fidelity of the cloned DNA. The sequence of each fragment was identical to the original gene.
Responses by murine splenocytes to the hsp60 polypeptides. We sought to determine the pattern of responses by splenocytes from BALB/c or C57BL/6 mice immunized with yeast cells or with rhsp60 to the recombinant fragments, Fl-F4. All fragments stimulated proliferation by spleen cells from BALB/c mice immunized either with yeast cells or with rhsp60 (figure 4). Splenocytes from animals not exposed to H. capsulatum yeast cells or from mice immunized with bovine serum albumin failed to mount a positive proliferative response to any recombinant fragment (data not shown).
Further analysis of the proliferation data revealed that the 2 groups of immunized BALB/c mice had different patterns of the response of cells in the presence of antigen by the response of cells in the absence of antigen.
Statistics. Student's t test was used to analyze differences between groups. The log-rank test was used to analyze data for surviving mice. imidazole, and 20 mM TRIS, pH 7.9. The denatured material was recovered in the supernatant after centrifugation at 20,000 g and then filtered through cellulose acetate membrane (pore size, 0.22 pm). The soluble supernatant-containing fragment also was filtered to remove particles. Each supernatant was loaded into a separate Ni2+-sepharose affinity column (His-Bind, Novagen) and washed with 20 mM imidazole, and the protein was eluted with 1 M imidazole in the same buffer. Eluate isolated under denaturing conditions was dialyzed against buffer (20 mM TRIS, pH 7.9, and 200 mM NaCl) containing decreasing concentrations of urea; F4 eluate was dialyzed against buffer alone. All eluates were concentrated by ultrafiltration. Protein concentration was determined by the method of Bradford [6] . The endotoxin content of the recombinant proteins was measured by use of the Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD). The fragments contained < 10 pg/ p,g protein.
PAGE and Western blot analysis.
Purified protein (5 p,g) was analyzed by SDS-PAGE using 10% polyacrylamide.
For Western blot analysis, 1 p,g of protein was electrophoresed in an SDS-12% polyacrylamide gel, electroblotted onto nitrocellulose membranes, and stained with Ponceau-S. Filters were incubated with 5% dried milk in TRIS-buffered saline (TBS). Nitrocellulose strips that bound protein were incubated overnight at 4°C with 1:2000 dilution of preimmune rabbit serum or of polyclonal monospecific anti~H. capsulatum hsp60 antibody. Excess antibody was removed by washing three times with 0.05% Tween 20 in TBS. The nitrocellulose strips were incubated for 2 h at 4°C with a I :2000 dilution of alkaline phosphatase-labeled goat antirabbit antibody (Kirkegaard & Perry, Gaithersburg, MD). The strips were washed with TBS containing 0.05% Tween 20, and the bands were incubated with 3.3 mg/mL nitroblue tetrazolium and 1.5 mg/mL 5-bromo-4-chloro-3-indolyl-phosphate in 100 mM NaCl, 5 mM MgCb, and 100 mM TRIS-Cl, pH 9.5.
Preparation and infection of mice with H. capsulatum yeasts. H. capsulatum yeasts (strain G2l7B) were prepared as previously described [4] . Lightly anesthetized mice were inoculated intranasally with sublethal (3 X 10 6 ) or lethal (3 X 10 7 ) doses of the yeast.
Immunization of mice with rhsp60, rhsp60 fragments, or H. capsulatum. Groups of 5-to 6-week-old mice were immunized subcutaneously with 100 p,g of rhsp60 or rhsp60 fragments suspended in MPL plus TDM plus CWS emulsion (Ribi ImmunoChern, Hamilton, MT). Two injections were given 2 weeks apart. In total, 200 p,g of rhsp60 or fragments was given to mice. Controls were injected simultaneously with an equal amount of bovine serum albumin emulsified in adjuvant. All proteins were suspended in adjuvant for immunization. Mice were immunized with viable yeasts as described previously [4] . Mice were injected initially with 10 6 yeasts subcutaneously, and 2 weeks later, they received 6 X J05 yeasts intravenously. Two weeks after the intravenous injection, mice were given 10 6 yeasts intraperitoneally. Splenocytes from mice were used 4 weeks after the last injection of yeasts.
Proliferation assays. Splenocytes from mice were isolated, and proliferation assays were done as described [4] . A proliferative response was considered positive when the response by cells to antigen exceeded by ?3-fold the response by cells in the absence of antigen. The stimulation index (SI) was calculated by dividing F2 F3 F4  F1 F2 F3 F4 ficed, and lungs, livers, and spleens were cultured. This time point was chosen because it represents the peak of infection in both BALB/c and C57BL/6 mice.
For BALB/c mice, the most striking findings were for F3. Yeast colony-forming units (cfu) in the animals' organs were significantly decreased compared with those for controls: by 1.2 log., (P < .01) in lungs, by 0.6 10gIO (P < .05) in spleens, and by 1.1 log\o (P < .01) in livers ( figure 6, top) . Recovery of H. capsulatum cfu in organs of mice immunized with the other protein fragments varied from 0.2 to 0.7 loglo, There was a statistically significant difference (P < .05) in the number of cfu in livers from F4-immunized and control BALB/c mice; however, F3 was the most potent mediator of protective efficacy in this strain of mice.
Studies with C57BL/6 mice demonstrated that F3 also was the most effective immunogen: cfu in lungs, livers, and spleens ofF3-immunized animals were reduced by 1.0 log., (P < .01), 0.5 10gIO (P < .05), and 0.7 10gIO (P < .01), respectively, compared with cfu in infected controls (figure 6, bottom). The decreases in cfu induced by F I, F2, and F4 were very modest (range, 0-0.3 10gIO cfu) compared with those for controls.
Subsequently, we examined the protective efficacy of the polypeptides in mice exposed to a lethal intranasal inoculum (3 X 10 Protective efficacy of recombinant polypeptides. We have shown that rhsp60 can protect BALB/c mice against lethal challenge with yeast cells [5] . In the current series of studies, we examined if any protein fragment could be protective in either BALB/c or C57BL/6 mice. In the initial experiments, we ascertained the protective efficacy of polypeptides in mice challenged with a sublethal inoculum (3 X 10 6 ) of yeast cells. Immunized animals and controls were inoculated 2 weeks after the last injection of antigen. One week later, they were sacri- 
Discussion
The hsp60 family is highly conserved among species and subserves many critical cellular functions, including transport of proteins and promotion of folding and assembly of polypeptides [7] [8] [9] . In addition to its intracellular biologic activities, this family of proteins is a prominent target of the humoral and cellular immune response to several pathogens, including H. capsulatum [4, 5, [10] [11] [12] . H. capsulatum hsp60 stimulates proliferation by T cells and is an immunodominant target of T cells from mice exposed to this fungus [4, 5] . Moreover, both native and recombinant forms of this antigen protect mice against infection [5] . Thus, H capsulatum hsp60 not only is antigenic but also can promote a protective immune response.
In this study, we sought to determine if the antigenic and immunogenic properties of H. capsulatum hsp60 could be mapped to a specific region of the protein. To accomplish this goal, we cloned overlapping gene segments and expressed them in the prokaryote E. coli. The fidelity of each gene segment was confirmed by sequencing and by Western blot analysis of the expressed proteins using a monospecific antiserum raised to the native protein. The polypeptides were tested for their ability to stimulate proliferation by lymphocytes from animals that had been immunized either with yeast cells or with rhsp60. The purpose of these experiments was to determine if recognition of epitopes was segregated to one or more fragments and ifthe proliferative responses could be correlated with protective efficacy. We focused on cell-mediated immune responses since they are the principal ann of immunity activated in response to infection with H. capsulatum [13] .
The results demonstrated that splenocytes from BALB/c mice immunized with either yeast cells or with rhsp60 responded to each polypeptide. Thus, each fragment of hsp60 was antigenic. However, the pattern of proliferative responses to each polypeptide differed among the 2 groups of sensitized mice: F3 generated the most vigorous stimulation of cells from yeast-immunized animals, whereas F I produced the highest 81 in mice injected with recombinant protein. Although the differences in SIs among the fragments were not dramatic, the hierarchy of SIs was distinct among the 2 groups of BALB/c mice. These findings suggest that antigenicity ofhsp60 epitopes derived from antigen-presenting cells (APC) is critically dependent on the immunogen (viable yeast cells vs. rhsp60 in adjuvant).
In order for APC to present antigen to T cells, the native protein must be degraded into peptide fragments. Antigen is internalized and digested by proteolytic enzymes present in either lysosomes or in cytosol [14] . Antigens processed in lysosomes are presented in the context of class II major histocompatibility complex molecules, whereas those degraded in cytosol are presented by class 1 major histocompatibility complex antigens. Several considerations may explain the different proliferative response profiles for yeast-immunized and rhsp60-immunized mice to the recombinant fragments of hsp60. First, rhsp60 was emulsified in adjuvant, consisting of immune modulators, which may modify handling of antigen by APC. In .... addition, the cytokines produced in response to injection of antigen suspended in adjuvant may be distinct from that generated by injection of live yeasts. Accordingly, these qualitative or quantitative differences in cytokine generation also may alter processing of antigen by APC. A second explanation is that there may be differences between native and recombinant antigen in either conformation or posttranslational modifications (or both). This would not be surprising since the recombinant protein is produced by a prokaryote. Thus, such alterations in the nature of the protein may change how a protein is degraded by an APC.
Third, it is possible that components of yeasts or yeast cell metabolites may alter the immune response to hsp60. Fourth, the quantity of hsp60 generated in response to infection with viable organisms is probably dissimilar from the amount of rhsp60 injected with adjuvant into mice. This quantitative difference may account for the nature of the epitopes generated by APC. Last, different subsets of T cells may be expanded by immunization with yeast cells than those expanded by immunization with rhsp60 in adjuvant. It should be stressed that these explanations are not exclusive; in fact, it is likely that more than one factor is operative.
An unanticipated finding was the failure of splenocytes from C57BL/6 mice immunized with yeast cells to respond to any of the polypeptides or to rhsp60, although spleen cells responded to native antigen. It is unlikely that the lack of response was caused by an inability of APC to internalize the polypeptides, since the fragments stimulated proliferation by cells from rhsp60-immunized C57BL/6 mice. The fact that the polypeptides induced proliferation by cells from rhsp60-immunized mice indicates that they were antigenic for this strain. This observation provides indirect evidence that conformation of proteins may alter immunogenicity.
Immunization of either strain of mouse with F3 produced the most striking effects on protection against a sublethal or a lethal challenge with yeast cells. In studies using a sublethal inoculum, the decrement in cfu was~10-fold in lungs and livers and less pronounced in spleens. The reason for the discrepancy between spleens and other organs has not been determined.
In the lethal challenge studies, F3 protected 50% of the animals. This result should be compared with those from our previous study, in which immunization with rhsp60 protected all mice given a lethal intranasal inoculum [5] . Several considerations may explain the differences in effectiveness between the first and the present study. First, in the prior study, we challenged mice with 1.5 X 10 7 yeasts, and in this one, the inoculum was doubled. The larger number of yeasts was used to underscore the efficacy of an immunogen. Second, since hsp60 from Mycobacterium tuberculosis possesses adjuvant properties [15] , H. capsulatum hsp60 might have an identical adjuvant effect, and the protein sequence responsible for this activity may not be contained in F3. Therefore, optimal efficacy of hsp60 as a vaccine may require the adjuvant region as well as F3. Third, the data unequivocally demonstrate that each polypeptide could stimulate proliferation by sensitized lymphocytes. Therefore, optimal protection may be achieved when all epitopes collaborate to stimulate T cells.
The survival studies revealed that mice who were immunized with F3 died within the same time frame as the animals from the other experimental groups. This finding suggests that the conditions used for immunization and challenge were at a threshold. With a higher inoculum, it is likely that nearly all mice would have died, and with a lower inoculum, the survival rate may have been higher.
Proliferation by T cells is a measure of antigenicity or superantigenicity. In practice, it is a simple screen that has utilities similar to skin testing. Therefore, we performed the proliferation studies to determine if the results would correlate with protective efficacy. The postulate was that the protective polypeptide would be the one that caused maximal stimulation. In this regard, F3 was the only polypeptide to manifest protective efficacy, yet it did not cause maximal stimulation of lymphocytes from either mouse strain immunized with rhsp60. These limited results indicate that intensity of proliferation cannot be used with certainty to predict which epitopes may be protective.
In conclusion, we have established that a protective domain exists within H. capsulatum hsp60. This region of the protein appears to account for most if not all of the protective efficacy of this protein for the 2 strains of mice used in the study. Future studies will attempt to identify if a peptide from F3 can protect mice against challenge with H. capsulatum.
